日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Framework for Locally Imputing and Predicting Biomarker Trajectories Under Irregular Monitoring: Application to Chronic Myeloid Leukemia

一种用于在不规律监测下局部推断和预测生物标志物轨迹的框架:以慢性粒细胞白血病为例

Montano-Campos, Felipe; Heagerty, Patrick; Haupt, Eric; Hahn, Erin; Radich, Jerald; Bansal, Aasthaa

Oncologist-Patient Concordance and Treatment Adherence in Chronic Myeloid Leukemia

肿瘤科医生与患者在慢性粒细胞白血病治疗中的一致性及治疗依从性

Montano-Campos, J Felipe; Hahn, Erin E; Haupt, Eric C; Radich, Jerald; Bansal, Aasthaa

Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102)

接受异基因移植或去甲基化药物/支持治疗的骨髓增生异常综合征患者的自付费用和经济困难(BMT CTN 1102)

Su, Christopher T; Saber, Wael; Bansal, Aasthaa; Li, Li; Nakamura, Ryotaro; Cutler, Corey; Roth, Joshua A; Wright, Winona; Steuten, Lotte; Ramsey, Scott D

Using Early Biomarker Change and Treatment Adherence to Predict Risk of Relapse Among Patients With Chronic Myeloid Leukemia Who Are in Remission

利用早期生物标志物变化和治疗依从性预测慢性粒细胞白血病缓解期患者的复发风险

Montano-Campos, J Felipe; Hahn, Erin; Haupt, Eric; Radich, Jerald; Bansal, Aasthaa

Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line setting

一线治疗中接受 CDK4/6 抑制剂治疗的 HR+/HER2- 转移性乳腺癌患者的医疗资源利用情况和费用

Behan, Emma; Veenstra, David L; Bansal, Aasthaa

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

降低强度异基因造血干细胞移植治疗高危骨髓增生异常综合征老年患者的成本效益:BMT CTN 1102 分析

Saber, Wael; Bansal, Aasthaa; Li, Lily; Scott, Bart L; Sangaralingham, Lindsey R; Thao, Viengneesee; Roth, Joshua A; Wright, Winona; Steuten, Lotte M G; Pidala, Joseph A; Mishra, Asmita; Maziarz, Richard T; Westervelt, Peter; McGuirk, Joseph P; Cutler, Corey; Nakamura, Ryotaro; Ramsey, Scott D

Productivity loss by cancer stage in patients newly diagnosed with hepatocellular carcinoma: A claims database analysis

新确诊肝细胞癌患者的癌症分期与生产力损失:一项基于理赔数据库的分析

Cheng, Spencer J; Bansal, Aasthaa; Veenstra, David L

A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia

一项针对中度发热性中性粒细胞减少症患者使用集落刺激因子的常规医嘱录入干预措施的实用性整群随机试验

Hershman, Dawn L; Bansal, Aasthaa; Sullivan, Sean D; Barlow, William E; Arnold, Kathryn B; Watabayashi, Kate; Bell-Brown, Ari; Le-Lindqwister, Nguyet A; Dul, Carrie L; Brown-Glaberman, Ursa A; Behrens, Robert J; Vogel, Victor; Alluri, Nitya; Ramsey, Scott D

Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors

当种族和民族因素被排除在结直肠癌复发风险预测模型之外时,模型中存在种族和民族偏见。

Khor, Sara; Haupt, Eric C; Hahn, Erin E; Lyons, Lindsay Joe L; Shankaran, Veena; Bansal, Aasthaa

Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing

TrACER (S1415CD) 研究中干预措施依从性差:脑脊液处方标准化医嘱录入的实用性随机试验

Hershman, Dawn L; Bansal, Aasthaa; Barlow, William E; Arnold, Kathryn B; Watabayashi, Kate; Bell-Brown, Ari; Sullivan, Sean D; Lyman, Gary H; Ramsey, Scott D